Yahoo Finance Today's Research Reports on Trending Tickers: Array BioPharma and Intercept Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / August 22, 2018 / U.S. markets continue to edge higher on Tuesday as optimism over trade talks and upbeat earnings pushed equities into the green. Additionally, the Federal Reserve will release details on the latest meeting on Wednesday. On Friday, Fed Chairman Jerome Powell is scheduled for a speech at the Kansas City Fed’s annual summer retreat. The Dow Jones Industrial Average hiked 0.25 percent to close at 25,822.29, while the S&P 500 Index have gained 0.21 percent to close at 2,862.96. The Nasdaq Composite Index increased 0.49 percent to close at 7,859.17.
Investment strategist at Edward Jones, Kate Warne said, “I think that this is optimism on at least some partial resolution of the trade negotiations as investors are expecting progress [on that front].” “If we reach new highs that’s great but I think it would be a reflection of the positive underlying fundamentals of very positive earnings growth and modest interest rates,” Warne added.
RDI Initiates Coverage on:
Array BioPharma Inc.
https://rdinvesting.com/news/?ticker=ARRY
Intercept Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=ICPT
Array BioPharma's stock jumped 3.59% Tuesday, to close the day at $13.86. The stock recorded a trading volume of 2,301,422 shares, which was below its three months average volume of 2,595,882 shares. In the last year, Array BioPharma's shares have traded in a range of 8.68 - 20.21. The share price has gained 59.68% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $15.87 is below its 200-day moving average of $16.25. Shares of Array BioPharma have fallen roughly 18.37 percent in the past month and are up 8.28 percent year-to-date.
Access RDI's Array BioPharma Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ARRY
On Tuesday, shares of Intercept Pharmaceuticals recorded a trading volume of 240,931 shares, which was below the three months average volume of 659,893 shares. The stock ended the day 3.5% higher at $107.00. The share price has fallen 12.24% from its 52 week high with a 52 week trading range of 51.05 - 121.92. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $98.56 is above its 200-day moving average of $76.26. Shares of Intercept Pharmaceuticals have gained roughly 14.07 percent in the past month and are up 83.16 percent year-to-date.
Access RDI's Intercept Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ICPT
Our Actionable Research on Array BioPharma Inc. (NASDAQ:ARRY) and Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
